Hot Flashes
Conditions
Keywords
hot flashes, melatonin, depression, sleep, luteinizing hormone, postmenopause
Brief summary
In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger the pulsatile release of GnRH and LH and also cause hot flashes. Thus, if melatonin suppressed this pulse generator in postmenopausal women, it might moderate hot flashes. This clinical trial tested the hypothesis that melatonin could suppress LH and relieve hot flashes.
Detailed description
Twenty postmenopausal women troubled by hot flashes underwent one week of baseline observation followed by 4 weeks of a randomized controlled trial of melatonin or matched placebo. The three randomized treatments were melatonin 0.5 mg 2.5-3 hours before bedtime, melatonin 0.5 mg upon morning awakening, or placebo capsules. Twelve of the women were admitted to the GCRC at baseline and at the end of randomized treatment for 24-hour sampling of blood for LH. Morning urine samples were collected twice weekly to measure LH excretion. Subjective responses measured throughout baseline and treatment included sleep and hot flash logs, the CESD and QIDS depression self-ratings, and the SAFTEE physical symptom inventory.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Postmenopausal woman * Troubled by hot flashes
Exclusion criteria
* Use of reproductive hormones other than continuous estrogen or progesterone hormone replacement * Any acute illness * Any anticipated changes of medication * Anemia (hemoglobin \<12) or poor veins Recent trans-time-zone jet travel, shift work, or irregular sleep habits Any neurological or pituitary disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Luteinizing hormone (blood) | — |
| CESD | — |
| Luteinizing hormone (urine) | — |
| Hot flashes log | — |
| Sleep log | — |
| QIDS | — |
Secondary
| Measure | Time frame |
|---|---|
| Other adverse events | — |
| SAFTEE inventory of symptoms and adverse effects | — |
Countries
United States